immunity News and Research

RSS

Encouraging results from SEEK's FLU-v Phase II study

SEEK, a leading UK privately-owned drug-discovery group, today announced encouraging results following the successful completion of its Universal Flu Vaccine Phase II challenge study.

7 Nov 2011

Rheumavax safe and feasible in treating RA

A vaccine designed to re-educate the immune system has been shown to be safe and feasible in the treatment of rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago.

7 Nov 2011

High dose of vitamin D3 safe and effective for obese adolescents

Vitamin D deficiency is common in Americans, and especially in overweight and obese adolescents, according to the National Institutes of Health. University of Missouri researchers have found that providing obese adolescents with a high daily dose of vitamin D3 is safe and effective in improving their vitamin D status.

2 Nov 2011

New protein microarray technology could eradicate malaria

A new research technology is revealing how humans develop immunity to malaria, and could assist programs aimed at eradicating this parasitic disease.

2 Nov 2011

AgonOx, MedImmune partner to advance OX40 agonist programs for cancer treatment

AgonOx today announced that it has entered into an exclusive global partnership with MedImmune, the global biologics arm of AstraZeneca, to develop agonists using its OX40 platform. MedImmune will lead further preclinical and clinical studies of this tumor-specific T-cell immunity stimulator for the potential treatment of cancer.

31 Oct 2011

New vaccine to eradicate meningitis

Outbreaks of meningitis can quickly reach epidemic proportions across a number of African countries, afflicting tens of thousands of people. Now a new vaccine appears capable of completely eradicating the disease.

28 Oct 2011

NK cells can fight against anthrax

One of the things that makes inhalational anthrax so worrisome for biodefense experts is how quickly a relatively small number of inhaled anthrax spores can turn into a lethal infection. By the time an anthrax victim realizes he or she has something worse than the flu and seeks treatment, it's often too late; even the most powerful antibiotics may be no help against the spreading bacteria and the potent toxins they generate.

28 Oct 2011

Microglia plays a key role in memory and learning

Immune system cells of the brain, which scavenge pathogens and damaged neurons, are also key players in memory and learning, according to new research by Duke neuroscientists.

27 Oct 2011

UNICEF issues statement clarifying reports of polio cases in Madagascar

UNICEF released a statement on Tuesday correcting an October 21 report by its office in Madagascar "expressing concern over a resurgence of polio in Madagascar after a routine health survey identified vaccine-derived poliovirus (VDPV) in several healthy children." According to the statement, "there was no re-emergence of polio in Madagascar," and "the last wild poliovirus case in Madagascar was detected in 1997."

27 Oct 2011

Breast milk component induces expression of P-glycoprotein

Researchers at Children's Hospital Los Angeles have found that a component of breast milk induces expression of P-glycoprotein (Pgp), a protein that is protective against necrotizing enterocolitis (NEC)--a complex, lethal disease that affects up to 7 percent of babies admitted to the NICU.

27 Oct 2011

Research questions aromatherapy safety

Aromatherapy oils are relied upon to relax, reduce stress and soothe aches and pains by many. However researchers from Chia-Nan University of Pharmacy and Science Tainan, Taiwan say these oils may not be completely harmless.

24 Oct 2011

American robin plays a key role in transmission of West Nile virus

After its initial appearance in New York in 1999, West Nile virus spread across the United States in just a few years and is now well established throughout North and South America.

21 Oct 2011

The Guardian interviews GlaxoSmithKline lead researcher about new malaria vaccine

The Guardian features an interview with Moncef Slaoui, now chair of research and development at GlaxoSmithKline, who discusses his 23-year involvement in the research leading to the RTS,S malaria vaccine that has shown to halve the risk of malaria among African children.

21 Oct 2011

Women with MET genetic variant and autoantibodies more likely to have autistic children

A study by researchers at UC Davis has found that pregnant women with a particular gene variation are more likely to produce autoantibodies to the brains of their developing fetuses and that the children of these mothers are at greater risk of later being diagnosed with autism.

20 Oct 2011

VEC and AMA release updated information guide, 'Vaccines and Teens'

This week at the annual meeting of the American Academy of Pediatrics, the Vaccine Education Center at The Children's Hospital of Philadelphia (VEC) and the American Medical Association released an updated information guide called Vaccines and Teens for parents and physicians, detailing the most current recommendations and information about critical immunizations for older children.

18 Oct 2011

New treatment approach for septic Listeria infection

Research underway at the Trudeau Institute could lead to new treatments for people sickened by Listeria and other sepsis-causing bacteria. Dr. Stephen Smiley's laboratory has published a study in the scientific journal Infection and Immunity that supports a new approach to treating these infections.

18 Oct 2011

Researchers identify 42 genetic regions associated with liver function

Researchers have identified a large number of areas in the human genetic code that are involved in regulating the way in which the liver functions, in a new study of over 61,000 people, published today in the journal Nature Genetics.

18 Oct 2011

Scientists discover a way to accurately map typhoid outbreaks in the city

In the mid-nineteenth century, John Snow mapped cases of cholera in Soho, London, and traced the source of the outbreak to a contaminated water pump. Now, in a twenty-first century equivalent, scientists funded by the Wellcome Trust working in Kathmandu, Nepal, have combined the latest in gene sequencing technology and global positioning system (GPS) case localisation to map the spread of typhoid and trace its source.

18 Oct 2011

ABI provides clinical update on company activities

Amarillo Biosciences, Inc. (ABI) today provided an update on company activities.

15 Oct 2011

Penn scientist tracks attitudes and H1N1 vaccination rates on Twitter

A unique and innovative analysis of how social media can affect the spread of a disease has been designed and implemented by a scientist at Penn State University studying attitudes toward the H1N1 vaccine. Marcel Salath-, an assistant professor of biology, studied how users of Twitter -- a popular microblogging and social-networking service -- expressed their sentiments about a new vaccine.

14 Oct 2011